Rchr
J-GLOBAL ID:202001008828078477
Update date: Nov. 07, 2024
Itonaga Hidehiro
イトナガ ヒデヒロ | Itonaga Hidehiro
Affiliation and department:
Job title:
Senior Research Associate
Research field (4):
Tumor biology
, Tumor diagnostics and therapeutics
, Hematology and oncology
, Molecular biology
Research keywords (11):
Epigenetic alterations
, Genetic alterations
, Molecular target
, Chemotherapy
, Allogeneic hematopoietic stem cell transplantation
, Adult T-cell leukemia-lymphoma
, Acute leukemia
, Myeloproliferative neoplasms
, Chronic myeloid leukemia
, Myelodysplastic syndrome
, Acute myeloid leukemia
Research theme for competitive and other funds (15):
- 2024 - 2025 2024年度 長崎県医師会医学研究助成金
- 2022 - 2025 「FLT3遺伝子変異を有する再発又は難治性の急性骨髄性白血病患者において、ギルテリチニブが同種造血幹細胞移植後成績に及ぼす影響」研究のためのヒストリカルデータ取得研究
- 2022 - 2025 FLT3遺伝子変異を有する再発又は難治性の急性骨髄性白血病患者における、ギルテリチニブが同種造血幹細胞移植後成績に及ぼす影響に関する観察研究
- 2023 - 2025 無人航空機を用いた血液製剤搬送の実行可能性と品質への影響に関する研究
- 2022 - 2025 Novel agents targeting DNA repair pathway regulated by protein arginine methyltransferases in myeloid neoplasms
- 2021 - 2024 MAGE A4陽性かつHLA-A*02:01陽性の切除不能進行・再発を有する固形がん患者を対象にMU-MA402Cの安全性及び忍容性を検討することを目的とした多施設共同第I相試験
- 2023 - 成人 T 細胞白血病に対する 移植後シクロフォスファミドを用いた非血縁者間末 梢血 幹細胞移植の安全性・有効性を検討する第 II 相試験
- 2020 - 2023 Dependency of AML cells on CARM1
- 2023 - 成人T細胞白血病/リンパ腫の治癒を目指したHTLV-1ウイルス標的樹状細胞ワクチン療法の確立: 薬事承認を目的とした第II相医師主導治験
- 2023 - アグレッシブ成人T細胞白血病リンパ腫を対象とした全国一元化レジス トリ・バイオレポジトリ研究
- 2019 - 2022 Targeting “Epigenetic Modifying” Enzymes in FPD/AML
- 2021 - The combination therapy with CARM1-inhibitor and JAK2-inhibitor for myeloid neoplasms with JAK2-V617F mutation
- 2018 - 2020 慢性骨髄性白血病における体細胞変異を有するクローン性造血の存在と患者背景に関する検討
- 2017 - 2020 Regulation of microRNA expression by DNMT in therapy-related leukemia
- 2011 - 慢性期慢性骨髄性白血病における微小残存病変の経時的変化とABL遺伝子変異の検討
Show all
Papers (108):
-
Hidehiro Itonaga, Takuya Fukushima, Koji Kato, Nobuaki Nakano, Takeharu Kato, Takashi Tanaka, Tetsuya Eto, Yasuo Mori, Toshiro Kawakita, Naoyuki Uchida, et al. Allogeneic transplantation for adult T-cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy. Hematological oncology. 2024. 42. 6. e3315
-
Makoto Yoshimitsu, Takashi Tanaka, Nobuaki Nakano, Koji Kato, Hiroyuki Muranushi, Masahito Tokunaga, Ayumu Ito, Jun Ishikawa, Tetsuya Eto, Satoko Morishima, et al. Comparative outcomes of various transplantation platforms, highlighting haploidentical transplants with post-transplantation cyclophosphamide for adult T-cell leukaemia/lymphoma. British journal of haematology. 2024
-
Atsushi Marumo, Yasunobu Nagata, Machiko Fujioka, Shuhei Kurosawa, Yuho Najima, Emiko Sakaida, Noriko Doki, Kentaro Fukushima, Shuichi Ota, Katsuhiro Shono, et al. Outcome of donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation in relapsed myelodysplastic syndrome. Cytotherapy. 2024
-
Miki Hashimoto, Takeharu Kato, Kenichi Yokota, Hikaru Sakamoto, Makiko Horai, Masataka Taguchi, Hidehiro Itonaga, Shinya Sato, Maki Baba, Koji Ando, et al. Improved survival among elderly patients with aggressive adult T-cell leukemia/lymphoma: Impact of mogamulizumab-containing chemotherapy. International journal of hematology. 2024
-
Machiko Fujioka, Hidehiro Itonaga, Hideyuki Nakazawa, Tetsuya Nishida, Keisuke Kataoka, Takashi Ikeda, Shinichi Kako, Ken-Ichi Matsuoka, Koji Adachi, Shini-Chiro Fujiwara, et al. Superior survival after unrelated allogeneic stem cell transplantation with low-dose ATG compared to low-dose TBI in myeloablative fludarabine/busulfan-based regimen for MDS on behalf of the adult MDS Working Group of the JSTCT. Transplantation and cellular therapy. 2024
more...
MISC (68):
-
糸永英弘. 慢性骨髄単球性白血病. 別冊 日本臨牀 血液症候群(第3版). 2024
-
糸永英弘. クローン性造血と骨髄系腫瘍. 血液内科. 2023. 86. 1. 42-47
-
糸永英弘, 木田理子, 土岐典子, 内田直之, 小澤幸泰, 福田隆浩, 上田恭典, 片山雄太, 諫田淳也, 一戸辰夫, et al. Outcomes of allo-HSCT for therapy-related MDS compared to de novo MDS by propensity-score matching. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 44th
-
糸永英弘. 慢性骨髄単球性白血病の病態と治療. 血液内科. 2021. 83. 5. 648-654
-
Shuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, Yuho Najima, Takeshi Kobayashi, Yukiyasu Ozawa, Yoshinobu Kanda, Shinichi Kako, Toshiro Kawakita, Ken-Ichi Matsuoka, et al. Comparison of Myeloablative Versus Reduced-Intensity Fludarabine/Busulfan Regimen in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. BLOOD. 2021. 138. 3692-+
more...
Books (15):
-
最新の臨床WEB
南江堂 2024
-
別冊 日本臨牀 血液症候群(第3版)
日本臨牀社 2024
-
血液内科
科学評論社 2023
-
血液内科
2021
-
悪性リンパ腫に対する新たな治療展開
クリニコ出版 2020 ISBN:9784910396040
more...
Lectures and oral presentations (157):
-
成人T細胞白血病リンパ腫に対する同種造血細胞移植における女性ドナー/男性レシピエントの影響
(第86回日本血液学会学術集会 2024)
-
成人T細胞白血病・リンパ腫に対するPTCYを用いたHLA半合致移植成績
(第86回日本血液学会学術集会 2024)
-
Progress in outcomes of allogeneic transplantation for atypical CML over two decades
(2024)
-
同種造血幹細胞移植が奏功した全身性炎症を伴う低リスクMDS
(第86回日本血液学会学術集会 2024)
-
Allogeneic transplantation as a therapeutic option for atypical chronic myeloid leukemia
(2024)
more...
Education (2):
- - 2013 Nagasaki University Graduate School of Biomedical Sciences Medical Science in Life Sciences and Radiation Research
- 1999 - 2005 Nagasaki University School of Medicine
Work history (14):
- 2023/04 - 現在 Nagasaki University Hospital Transfusion and Cell Therapy Unit
- 2023/04 - 現在 長崎大学病院 移植医療センター 組織移植部門
- 2022/04 - 2023/03 長崎大学病院 移植医療センター 造血幹細胞移植部門
- 2021/08 - 2023/03 Nagasaki University Hospital Department of Hematology Research associate
- 2018/12 - 2021/07 Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami Department of Biochemistry and Molecular Biology Post-doctoral
- 2018/12 - 2021/07 Atomic Bomb Disease Institute, Nagasaki University Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit
- 2016/04 - 2018/11 Nagasaki University Hospital Department of Hematology Research associate
- 2013/04 - 2016/03 Sasebo City General Hospital Department of Hematology Manager
- 2012/06 - 2013/03 Sasebo City General Hospital Department of Hematology Assistant manager
- 2012/04 - 2012/05 Nagasaki University Hospital Department of Hematology
- 2010/04 - 2012/03 Nagasaki University Graduate School of Biomedical Sciences Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit
- 2007/04 - 2010/03 Nagasaki University Hospital Department of Hematology Senior resident
- 2006/04 - 2007/03 Isahaya General Hospital Junior resident
- 2005/04 - 2006/03 Nagasaki University Hospital Junior resident
Show all
Committee career (8):
- 2024/06 - 現在 日本輸血・細胞治療学会 評議員
- 2024/03 - 現在 日本輸血・細胞治療学会 九州支部会 評議員
- 2023/04 - 現在 日本造血・免疫細胞療法学会 骨髄異形成症候群(成人)-WG 責任者
- 2023/01 - 現在 アグレッシブ成人T細胞白血病・リンパ腫コンソーシアム 運営委員
- 2022/04 - 現在 Japanese Society for Transplantation and Cellular Therapy Councilor
- 2017/04 - 現在 日本血液学会九州支部 評議員
- 2016/09 - 現在 Japanese Society of Hematology Councilor
- 2021/07 - 2023/07 日本血液学会 造血器腫瘍診療ガイドライン (2023)作成委員会
Show all
Awards (5):
- 2024/03 - 長崎県医師会 長崎県医師会医学研究助成金
- 2022/09 - 公益財団法人 武田科学振興財団 医学系研究助成 (がん領域 (臨床))
- 2020/03 - The Japan Society for Hematopoietic Cell Transplantation JSHCT Working Group Research Award Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and related disorders
- 2017/06 - Nagasaki University School of Medicine The Tsunoo Award for Scientific Excellence The relationship of genomic and epigenomic alterations with clinical response in myeloid neoplasms
- 2014/05 - Japanese Society of Hematology Best poster awards of the 5th Japanese Society of Hematology International Symposium Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B
Association Membership(s) (7):
日本組織移植学会
, America Society of Hematology
, The Japan Society of Transfusion Medicine and Cell Therapy
, Japanese Society of Medical Oncology
, The Japanese Society for Transplantation and Cellular Therapy
, The Japanese Society of Internal Medicine
, Japanese Society of Hematology
Return to Previous Page